ArriVent BioPharma, Inc. (AVBP): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

38.46M
Year ended 2025-12-31
2023-12-31: 2.14M2024-12-31: 31.47M2025-12-31: 38.46M38.46M
2023-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-3138.46M+22.2%2026-03-05, From 2025-01-01
2024-12-3131.47Mn/m2026-03-05, From 2024-01-01
2023-12-312.14Mn/a2025-03-03, From 2023-01-01